{Reference Type}: Case Reports
{Title}: Cutaneous Mucormycosis in a Patient of Severe COVID-19 Pneumonia: A Rarer than Rare Case Report.
{Author}: Tambe RR;Hinduja A;Sunil S;Varaiya A;Joshi A;
{Journal}: Indian J Crit Care Med
{Volume}: 25
{Issue}: 11
{Year}: Nov 2021
暂无{DOI}: 10.5005/jp-journals-10071-24026
{Abstract}: Coronavirus disease-2019 (COVID-19)-associated mucormycosis is on the rise in the Indian subcontinent. We report a unique case of cutaneous mucormycosis in a case of newly diagnosed young diabetic patient with severe COVID-19 pneumonia with post-COVID lung fibrosis. Neither did he have any preceding trauma or wound, nor was there any evidence of any secondary dissemination. Cutaneous mucormycosis without evidence of either is unheard off. Possible risk factors in this case were multiple bacterial secondary infections with the use of higher antibiotics, use of voriconazole for possible aspergillosis, and steroid use.<BR><B>UNASSIGNED: </B>Tambe RR, Hinduja A, Sunil S, Varaiya A, Joshi A. Cutaneous Mucormycosis in a Patient of Severe COVID-19 Pneumonia: A Rarer than Rare Case Report. Indian J Crit Care Med 2021;25(11):1318-1319.